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Abstract
How the myocardium undergoes geometric, structural and molecular alterations that results in an
end phenotype as might be seen in patients with dilated cardiomyopathy or following myocardial
infarction (MI), is still poorly understood. Structural modification of the left ventricle which occurs
during these pathological states results from chronic changes in loading conditions and is commonly
referred to as “remodeling.” Remodeling may occur from increased wall stress in the face of
hypertensive heart disease, valvular disease or perhaps most dramatically, following permanent
coronary occlusion(Opie et al., 2006). A fundamental derangement of myocyte function is the most
common perception for the basis of “remodeling” but the role of cells in the heart other than the
muscle cell must of course be considered. While studies of the myocyte have been extensive, cardiac
fibroblasts (CFs) have been studied less than myocytes. The fibroblast has a broad range of functions
in the myocardium ranging from elaboration and remodeling of the extracellular matrix (ECM), to
communication of a range of signals within the heart, including electrical, chemical and mechanical
ones(Baudino et al., 2006). Integrins are cell surface receptors that are instrumental in mediating
cell-matrix interactions in all cells of the organism, including all types within the myocardium. This
review will focus on the role of integrins and related proteins in the remodeling process, with a
particular emphasis on the cardiac fibroblast. We will illustrate this function by drawing upon two
unique mouse models with perturbation of proteins linked to integrin function.
Integrin function: generalities and emphasis on the cardiac fibroblast
Integrins are heterodimeric transmembrane receptors composed of α and β subunits.(Hynes,
1987;Giancotti and Ruoslahti, 1999) The general arrangement of integrin subunits is that of a
large extracellular domain (700–1100 amino acids), a single transmembrane segment and a
short cytoplasmic tail, ranging from 20–60 amino acids.(Humphries, 2000). Ligand binding
occurs to the extracellular domain of the integrin heterodimer, a process that is modified by
range of amino acids spread throughout both the extracellular and transmembrane domains
(Takada et al., 2007). The cytoplasmic domain of many of the β subunits is highly homologous,
while the α subunits sequences are significantly more diverse. It is through the cytoplasmic
tail that the integrins bind both a range of cytoskeletal linker molecules and also signal.
Importantly, it has been recognized that binding of talin to integrin tails produces a change in
integrin affinity for ligand, a process termed integrin activation(Calderwood,
2004;Calderwood et al., 1999). Integrin activation may not be solely restricted to talin binding
but also may involve binding of other proteins to the integrin tail, such as kindlin-3(Moser et
al., 2008). For additional data on detailed integrin structure the reader is referred to the excellent
reviews such as(Green et al., 1998;Humphries, 2000;Hynes, 2002;Takada et al., 2007).
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Initial studies determined that integrins were essential for adhesion of cells to the extracellular
matrix (Hynes, 1981;Wylie et al., 1979;Ginsberg et al., 1983). Therefore, integrins are
fundamental components in the interaction between the ECM and the cardiac myocytes or
fibroblasts. Still, as shown in figure 1, it is now clear that integrins are multifunctional receptors
with purposes that in addition to adhesion, include the regulation of cellular phenotype in the
developing and post-natal myocardium, modulating such processes such as cell survival, cell
migration, as well as remodeling of the cellular cytoskeleton and focal adhesion. A most
intriguing role of integrins in the heart is their ability to serve as mechanotransducers during
normal development and in response to physiological and pathophysiological signals. (Ingber,
1998;Simpson et al., 1999;Chen, 2008;Schwartz and DeSimone, 2008;Parker and Ingber,
2007);
Most importantly, it is well accepted that integrins are important signal transducers(Schwartz
and Ginsberg, 2002;Clark and Brugge, 1995;Hynes, 2002) The integrins function in a bi-
directional manner across cell membranes. Ligand binding to the integrins results in
intracellular signaling events, a cascade termed “outside-in” signaling. In this role, the integrins
can influence a wide range of activities of the type mentioned above, including alterations in
cell morphology, migration, proliferation, differentiation, survival; gene expression,
suppression of tumorigenicity, changes in intracellular pH or concentration of cytosolic
Ca++. Since the integrins do not themselves possess enzymatic activity, they signal through
activation of downstream molecules such as kinases pp125 focal adhesion kinase (FAK) or
integrin linked kinase (ILK), small GTPases such as Rho or Rac, and regulation of cytoskeletal
components such as talin, paxillin or p130CAS, several of which may bind directly to the
cytoplasmic domain of the integrin heterodimer. Ultimately, signaling from the integrins may
influence pathways through which other cellular effectors (such as growth factors) may also
signal, including those requiring Akt, Raf, phosphoinositide 3-kinase (PI3-K), or mitogen-
activated protein kinases (MAPKs)/extracellular-signal regulated kinases (ERKs).
Integrin function can also be modified by agonists that bind to non-integrin cellular receptors
and in turn modify integrin activation; a process termed “inside-out” signaling. Here, both
increased binding of integrin to ligand as well as clustering of multiple integrins in close spacing
within the cell membrane occurs. It is clear that integrin clustering in both myocytes and
fibroblasts in the myocardium is associated with chemical and mechanical signaling.
The integrin family is large, with over 18 α and 8 β subunits identified in mammals. From these
various subunits, over 24 pairs of integrins receptors can arise. While it is clear that all
combinations of αβ heterodimers can form, how the preferential pairing of subunits occurs in
a specific cell is not clear. The complex nature of this protein family is increased to an even
greater extent by the numerous splice variant isoforms of individual subunits, including some
expressed in the heart(de Melker and Sonnenberg, 1999;Song et al., 1993;Burkin and Kaufman,
1999). The integrins expressed on a particular cell type can be unique and can vary depending
on developmental stage or pathological state. (Table I) Further complexity is evident since a
single integrin receptor can bind to one or several ligands and in addition, a single ligand can
be bound by several integrin heterodimers. For example cardiac fibroblasts express α5β1 (a
fibronectin (FN)/osteopontin (OPN) binding integrin) as well as αvβ1, αvβ3, andαvβ5 (which
bind FN, OPN as well as vitronectin) (Terracio et al., 1989;Terracio et al., 1991;Maitra et
al., 2000;Ross and Borg, 2001). In addition, components of the ECM can bind to several
different integrins, allowing potentially for even further functional redundancy and complexity.
CFs can play critical roles in cardiac remodeling and may do so via an ECM/integrin
interaction. The fibroblasts appear to play diverse functions. For example, Gullberg noted that
PDGF-stimulated collagen gel contraction by CFs could be partly inhibited by β1 integrin
antibodies(Gullberg et al., 1990). With stretch of cultured myocytes, release of angiotensin II
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(AngII) occurred(Sadoshima et al., 1993). Once produced, AngII stimulation of CFs modulated
integrin localization and increased expression of both α8 and β1 integrins(Burgess et al.,
1994;Thibault et al., 2001). Further, AngII increased adhesion of fibroblasts to collagen I via
PKC epsilon(Stawowy et al., 2005). 14 day AngII infusion in rats caused increased α8β1
expression in myofibroblasts(Bouzeghrane et al., 2004). Carver et.al. have shown that α1β1
integrins play a role in collagen gel contraction by rodent CFs(Carver et al., 1995). Several
studies have focused on various integrins, cytokines and signaling in the function of cardiac
fibroblasts. For example stretch of rat cardiac fibroblasts resulted in both ERK2 and JNK1
activation, and activation varied dependent on the integrin subunits (e.g. α4 vs. α5) bound by
ECM(MacKenna et al., 1998). Integrin overexpression can increase expression and activation
of TGF-β, an important cytokine in the fibrotic response of the heart(Ma et al., 2003;Wang et
al., 1999). Conversely, TGF-β stimulation of fibroblasts was found to increase expression
ofα5β1 integrins(Dalton et al., 1999).
In the intact heart only a few studies on integrins and fibroblasts are available. Burgess, et. al.
studied rats subjected to treadmill exercise or hypertension. β1 integrin was elevated with both
hypertrophic stimuli; α1 and α2 levels both decreased, but α5 increased in the exercise group
and decreased in the hypertensive one. Liu’s group studied the role of β integrins after
myocardial infarction (MI) using rat and mouse as model systems. Both β1 and β3 integrins
were low basally but increased at the infarct zone by day 3 post-MI, peaking at day 7 post-MI,
then returned towards baseline. In line with the cell-type specific expression of integrins, β1A
was found primarily on fibroblasts and inflammatory cells while β1D was expressed on
myocytes and β3 was detected principally on endothelial and smooth muscle cells in the peri-
infarct vessels. Thus while several studies of integrin function in the cardiac fibroblast have
been performed, a full understanding of the role of integrins in these cells, particularly in the
face of cardiac pathologies, is far from complete. For the remainder of this review, we would
like to use two examples to further illustrate the function of integrins and related proteins in
the myocardium and cardiac fibroblast.
Osteopontin is involved in hypertrophic and fibrotic responses of the heart
Osteopontin is a multifunction glycoprotein that is a member of the SIBLING (small integrin
binding Ligand N-linked glycoproteins) family(Scatena et al., 2007). It is a soluble cytokine;
a phosphoprotein that is secreted by many cells including cardiac myocytes and fibroblasts.
As a matricellular molecule it does not serve a structural role in the ECM, but rather facilitates
ECM responses. It can bind to numerous integrins includingαvβ3,αvβ1, αvβ5, α4β3, α4β1,
α5β1, α8β1, α9β1, andα4β7, as well as the hyaluronic acid receptor CD44. Functioning through
a series of downstream signaling pathways it can direct cellular adhesion, migration and
survival. Despite its multiple functions, OPN homozygous knockout mice survive(Liaw et
al., 1998) and therefore were used in our prior work by Collins, et.al. to study to function of
OPN in the myocardium(Collins et al., 2004).
Continuous infusion of AngII via osmotic minipump was performed in wild-type mice at levels
which evoked a 50 mmHg rise in systolic blood pressure. With this, increases in myocardial
OPN transcript expression was detected by 4 days into the infusion, with subsequent
normalization to baseline levels by 3 weeks. These results suggested that OPN is a component
of the myocardial stress response invoked by AngII. Given this, the importance of OPN was
investigated by use of the OPN KO mice mentioned above. With this infusion, hypertension,
and related stress, the wild-type mice underwent the expected increases in heart weight/body
weight ratios, indicative of ventricular hypertrophy, but the OPN KO mice showed a blunted
morphometric response, despite similar increases in molecular markers of hypertrophy. With
this, the amount of AngII induced fibrosis was assessed in the myocardium and it was seen
that the absence of OPN leads to a reduced fibrotic response, even though ECM production
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(fibronectin, collagen I), β1 integrin and TGFβ transcripts, all increased similarly in the WT
and KO mice. Given this, the effect of OPN on fibroblast function was evaluated using cardiac
fibroblasts isolated from WT and OPN KO mice. The KO fibroblasts were seen to have reduced
adhesion and proliferation, properties that could be partially restored towards normal by
addition of exogenous OPN protein to the cultured KO cells. In support of these results were
studies from Singh’s group(Trueblood et al., 2001;Xie et al., 2004) which showed that OPN
KO hearts had a reduced hypertrophic response following aortic constriction, and also showed
blunted collagen production and fibrosis following myocardial infarction. Finally, recent data
from Lenga, et.al.(Lenga et al., 2008), has linked OPN to the formation of mature focal
adhesions and transformation of fibroblasts to myofibroblasts, a process important for
formation of scars during processes such as the post-myocardial infarction state. Thus it appears
that OPN, as a protein produced by both cardiac myocytes and fibroblasts, is critically linked
to both hypertrophic and fibrotic response pathways in the myocardium. It provides an
important example of a substance involved in cell-matrix adhesion and modulation of integrin
function, which could be potentially modulated in amount or function, to avoid adverse cardiac
remodeling.
Focal adhesion kinase is linked to cardiac fibroblast proliferation, migration
and transformation towards a myofibroblast phenotype
A second example of how integrin/focal adhesion function is involved in the cardiac stress
response comes from our recent work on focal adhesion kinase (FAK)(Kang et al., 2006). As
discussed above, integrins do not possess their own kinase activity and therefore to transduce
signals, utilize a host of downstream kinases. Principal amongst them is FAK. We sought to
assess the function of FAK in adult cardiac fibroblasts (CF) by culturing CF from homozygous
FAK “floxed” mice originally produced by Beggs, et.al.(Beggs et al., 2003). With these cells
in hand, we deleted FAK expression by infecting the cells with a recombinant adenovirus
producing Cre recombinase. We thus produced cells devoid of FAK. First we assessed how
these cells displayed focal adhesions (FAs) and expressed focal adhesion proteins. We found
that the FAs were morphologically preserved and that the FA proteins vinculin, paxillin and
talin were expressed equally in KO and control cells, but that in the FAK deficient CFs,
expression of Pyk2, a cytoplasmic tyrosine kinase that shares approximately a 45% amino acid
sequence identity with FAK, was upregulated. The FAK KO CF had normal adhesion,
increased proliferation and reduced migration, when stimulated by platelet derived growth
factor BB (PDGF-BB). Utilizing FAK-related non-kinase (FRNK) as an inhibitor of FAK
function, we found that Pyk2 was not increased in the FRNK expressing, wild-type CF. FRNK
caused reduction of CF migration, but did not alter cell proliferation, suggesting that Pyk2 was
at least partly responsible for the proliferation defects in the FAK KO CF, but that it was not
involved in the migratory defect seen in these cells.
Interesting work performed by Clemente and Franchini(Clemente et al., 2007) has begun to
study the function FAK in vivo, and showed that FAK was present in both myocytes and
fibroblasts of the murine heart, but increased dominantly in non-myocytes following aortic
constriction. When mice were treated via single jugular vein injection with siRNA directed
towards FAK, FAK expression was reduced over 70% and the mice were seen to have reduced
fibrosis and collagen production following aortic constriction. Importantly, work by Insel and
co-workers(Swaney et al., 2006), has linked FAK, like OPN, to the transformation of
fibroblasts to myofibroblasts. Thus, FAK as an important mediator of integrin signaling appears
also linked to CF proliferation, migration and conversion of CFs to myofibroblasts.
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SUMMARY
In this review we have begun to illustrate how integrins and their related ECM/matricellular
and focal adhesion proteins, such as osteopontin and focal adhesion kinase, appear critically
involved in the proliferative and fibrotic responses of the stressed or injured myocardium. Study
into proteins of these types has just begun and a great deal of work is necessary to more fully
understand their importance in cardiac disease processes. In this regard, caveats must be
appreciated as we seek additional information about the function of these proteins in fibroblast
function including the organ and species-specific nuances of fibroblasts, “not all fibroblasts
are created equal;” that studies of cells from one developmental stage may yield unique results
as compared to another (i.e. embryonic, neonatal and adult fibroblasts form the heart may have
distinct properties); that culture studies may not always port-over to ones produced in the intact
animal and similarly study in 2-dimensional culture may be different than those performed in
3D culture. Much work is still necessary but our progress to date surely illustrates how
modulation of focal adhesion proteins may be an interesting future therapeutic target for
cardiovascular diseases.
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Figure 1.
Integrins are multifunctional cell surface receptors.
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